Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08% |
| Dec 31, 2025 | 52.61% |
| Sep 30, 2025 | 34.04% |
| Jun 30, 2025 | 18.40% |
| Mar 31, 2025 | -19.25% |
| Dec 31, 2024 | -3.74% |
| Sep 30, 2024 | -12.63% |
| Jun 30, 2024 | 19.67% |
| Mar 31, 2024 | -26.10% |
| Dec 31, 2023 | -2.95% |
| Sep 30, 2023 | 46.43% |
| Dec 31, 2017 | -73.52% |
| Sep 30, 2017 | 605.45% |
| Jun 30, 2017 | -0.45% |
| Mar 31, 2017 | -102.37% |
| Dec 31, 2016 | -108.42% |
| Sep 30, 2016 | -184.57% |
| Jun 30, 2016 | -92.74% |
| Mar 31, 2016 | -101.73% |
| Dec 31, 2015 | 61.47% |
| Sep 30, 2015 | 115.74% |
| Jun 30, 2015 | -96.49% |
| Mar 31, 2015 | -30.83% |
| Dec 31, 2014 | 2,736.50% |
| Sep 30, 2014 | -119.08% |
| Jun 30, 2014 | 644.49% |
| Mar 31, 2014 | -17.44% |
| Dec 31, 2013 | -85.73% |
| Sep 30, 2013 | 1.55% |
| Jun 30, 2013 | -34.26% |
| Mar 31, 2013 | -114.20% |